We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01457404
First Posted: October 24, 2011
Last Update Posted: October 26, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Brown University
Providence VA Medical Center
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Mark McGovern, Dartmouth-Hitchcock Medical Center
  Purpose
The purpose of this study is to assess the safety and practicality, feasibility and efficacy of ICBT for co-occurring PTSD and substance use disorders within the OEF/OIF/OND Veterans population, as delivered by routine clinicians at the Veterans Affairs.

Condition Intervention Phase
Stress Disorder, Post-Traumatic Substance-Related Disorders Behavioral: Integrated Cognitive Behavioral Therapy Behavioral: Treatment-as-usual Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Integrated Cognitive Behavioral Therapy for Co-Occurring PTSD and Substance Use Disorders

Resource links provided by NLM:


Further study details as provided by Mark McGovern, Dartmouth-Hitchcock Medical Center:

Primary Outcome Measures:
  • Decrease from baseline in Clinician Administered PTSD Scale (CAPS) score (PTSD symptom severity) at 3-months and at 6-months [ Time Frame: Baseline, post-treatment, 3 months post treatment ]

Secondary Outcome Measures:
  • Reduction from baseline in substance use severity (Addiction Severity Index [ASI]) at 3-months and at 6-months [ Time Frame: Baseline, post treatment, 3 months post treatment ]

Enrollment: 56
Study Start Date: February 2011
Study Completion Date: June 2015
Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Integrated Cognitive Behavioral Therapy
Integrated Cognitive Behavioral Therapy (ICBT) is a non-exposure based, manual-guided individual or group therapy. ICBT consists of 3 learning and skill components designed to improve PTSD symptoms and substance use: 1) Patient education about PTSD and its relation to substance use and treatment; 2) Mindful relaxation: A behavioral anxiety reduction skill including centering and breathing techniques; and 3) Cognitive restructuring/flexible thinking: A cognitive approach and functional analysis of the link among emotions, cognitives and situations.
Behavioral: Integrated Cognitive Behavioral Therapy
Individual or group ICBT, approx. 12 sessions, one session per week
Other Names:
  • ICBT
  • CBT for PTSD
  • CBT
Active Comparator: Treatment-as-usual
Treatment-as-usual (TAU) is the typical outpatient treatment that patients would receive ordinarily at the PVAMC Substance Abuse Treatment Program (SATP) or PTSD Clinic.
Behavioral: Treatment-as-usual
Individual or group therapy as usual within the SATP or PTSD clinics at the PVAMC
Other Name: TAU

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. OEF/OIF/OND Veteran status;
  2. Diagnosis of PTSD confirmed by the Clinician Administered PTSD Scale (CAPS) with a total symptom score of 44 or more;
  3. Diagnosis of a substance use disorder (abuse or dependence) and confirmed by the Structured Clinical Interview of DSM-IV Section E (SCID-E);
  4. Willing and able to provide informed consent;

Exclusion Criteria:

  1. Acute psychotic symptoms (however, persons with a psychotic disorder are eligible if their symptoms are stable and they are well connected with appropriate mental health services);
  2. Psychiatric hospitalization or suicide attempt in the past month (however, if the hospitalization or attempt was directly related substance intoxication or detoxification and ther person is currently stable, they are eligible);
  3. Medical or legal situations are unstable such that ability to participate in the full duration of the study seems unlikely.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01457404


Locations
United States, Rhode Island
Providence Veterans Affairs Medical Center (PVAMC)
Providence, Rhode Island, United States, 02908
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Brown University
Providence VA Medical Center
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Mark P. McGovern, Ph.D. Dartmouth-Hitchcock Medical Center
  More Information

Responsible Party: Mark McGovern, Associate Professor of Psychiatry and of Community and Family Medicine, Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT01457404     History of Changes
Other Study ID Numbers: 5R01DA030102 ( U.S. NIH Grant/Contract )
First Submitted: October 4, 2011
First Posted: October 24, 2011
Last Update Posted: October 26, 2015
Last Verified: October 2015

Keywords provided by Mark McGovern, Dartmouth-Hitchcock Medical Center:
integrated cognitive behavioral therapy
cognitive behavioral therapy
addiction
posttraumatic stress disorder (PTSD)

Additional relevant MeSH terms:
Disease
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Substance-Related Disorders
Pathologic Processes
Trauma and Stressor Related Disorders
Mental Disorders
Chemically-Induced Disorders